version of the Guidelines, which is freely available via the ESC and EAS websites and
hosted on their journals' websites (EHJ and Atherosclerosis Journal). The National Cardiac …

The physiopathology of fatty liver and metabolic syndrome are influenced by diet, life style
and inflammation, which have a major impact on the severity of the clinicopathologic …

Diabetic nephropathy (DN) is the leading cause of end stage renal disease (ESRD).
Although the pathogenesis of DN is multifactorial, local inflammatory stress may result from …

Altered lipid metabolism characterizes proteinuria and chronic kidney diseases. While it is
thought that dyslipidemia is a consequence of kidney disease, a large body of clinical and …

The incidence of chronic kidney disease (CKD) in the US continues to increase, and now
over 10% of the US population has some form of CKD. Although some patients with CKD will …

Background: Many effects of statins on non–cardiovascular disease (non-CVD) outcomes
have been reported. Purpose: To evaluate the quantity, validity, and credibility of evidence …

The most common cause of end stage renal disease (ESRD) requiring dialysis is diabetes.
Both environmental and genetic factors have been postulated as the risk factors of Diabetic …

In the past 15 years, major advances have been made in understanding the role of lipids in
podocyte biology. First, susceptibility to focal segmental glomerulosclerosis (FSGS) and …

Renal fibrosis is the principal process underlying the progression of chronic kidney disease
(CKD) to endstage renal disease (ESRD). It is a relatively uniform response involving …

Chronic kidney disease (CKD) is a serious health problem that can affect various systems in
the human body. Renal failure promotes mechanisms of premature cellular aging and also …